■
News & Notice
■
About us
•
Mission
•
Message
•
Brief History
•
Organization
■
Achievements -
Commercialized Health Products
■
MBRI Pipeline
■
R & D
• Immunology
-
Active immunotherapy against Hepatitis C virus infection
-
T-cell targeted anti-rheumatic drugs
-
Diagnostics
• Oncology
-
Anti-angiogenic protein, LK8
-
Anti-angiogenic gene therapy
• Biopharmaceutical Engineering
-
Recombinant protein expression systems
-
Pharmaceutical engineering
• Hematology & Endocrinology
-
Recombinant factor IX
-
Recombinant parathyroid hormone
•
Cord Blood Bank
■
Collaborations
■
Contact us
Copyright© 2004 MOGAM Biotechnology Research Institute. All Rights Reserved.
